ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Cotinga Pharmaceuticals Inc

Cotinga Pharmaceuticals Inc (COT)

0,035
0,00
(0,00%)
Geschlossen 11 Januar 10:00PM

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

Current Price
0,035
Gebot
0,025
Fragen
0,06
Volumen
-
0,00 Tagesbereich 0,00
0,00 52-Wochen-Bereich 0,00
Handelsende
0,035
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
Durchschnittliches Volumen (3 Mio.)
-
Finanzvolumen
-
VWAP
-

COT Neueste Nachrichten

Cotinga Pharmaceuticals Releases Additional Interim Data of Phase 1b/2a Combination Trial of COTI-2 in Solid Tumors

TORONTO and BOSTON, July 18, 2019 (GLOBE NEWSWIRE) -- Cotinga Pharmaceuticals Inc. (TSX Venture: COT) (“Cotinga” or the “Company”), a clinical-stage pharmaceutical company advancing a pipeline...

Cotinga Pharmaceuticals Doses First Patient in Third Cohort of Phase 1b/2a Combination Trial of COTI-2 in Solid Tumors

TORONTO and BOSTON, June 27, 2019 (GLOBE NEWSWIRE) -- Cotinga Pharmaceuticals Inc. (TSX Venture: COT) (“Cotinga” or the “Company”), a clinical-stage pharmaceutical company advancing a pipeline...

Cotinga Pharmaceuticals Announces Initiation of Next Cohort of Phase 1b/2a Combination Trial of COTI-2 in Solid Tumors

TORONTO and BOSTON, June 05, 2019 (GLOBE NEWSWIRE) -- Cotinga Pharmaceuticals Inc. (TSX Venture: COT) (“Cotinga” or the “Company”), a clinical-stage pharmaceutical company advancing a pipeline...

Cotinga Pharmacueticals Announces Closing of Second Tranche of Unit Offering

TORONTO and BOSTON, June 04, 2019 (GLOBE NEWSWIRE) -- Cotinga Pharmaceuticals  Inc. (TSX Venture: COT) (“Cotinga” or the “Company”), a clinical stage biopharmaceutical company advancing a...

Cotinga Pharmacueticals Announces Closing of Unit Offering

TORONTO and BOSTON, May 22, 2019 (GLOBE NEWSWIRE) -- Cotinga Pharmaceuticals Inc. (TSX Venture: COT) (“Cotinga” or the “Company”), a clinical stage biopharmaceutical company advancing a pipeline...

Cotinga Pharmaceuticals Announces Management and Board Changes

LONDON, Ontario and BOSTON, July 02, 2018 (GLOBE NEWSWIRE) -- Cotinga Pharmaceuticals Inc. (TSX Venture:COT) (OTCQB:COTQF) (“Cotinga” or the “Company”), a clinical-stage pharmaceutical company...

Cotinga Pharmaceuticals Announces FDA Clearance of Significant Protocol Changes for COTI-2 Clinical Program

LONDON, Ontario and BOSTON, May 24, 2018 (GLOBE NEWSWIRE) -- Cotinga Pharmaceuticals Inc. (TSX-V:COT) (OTCQB:COTQF) (“Cotinga” or the “Company”), a clinical-stage pharmaceutical company...

Cotinga Pharmaceuticals Closes $2.0M Private Placement

LONDON and BOSTON, May 04, 2018 (GLOBE NEWSWIRE) -- Cotinga Pharmaceuticals Inc. (TSX Venture:COT) (OTCQB:COTQF) (“Cotinga” or the “Company”), a clinical-stage pharmaceutical company advancing...

Cott Announces Expiration of Tender Offer for 8.0% Senior Subordinated Notes Due 2011

TORONTO and TAMPA, Fla., Nov. 30 /PRNewswire-FirstCall/ -- Cott Corporation (NYSE: COT; TSX: BCB) announced today the expiration of the previously announced cash tender offer and consent...

Cott Announces Tender Offer and Consent Solicitation

TORONTO and TAMPA, Fla., Oct. 29 /PRNewswire-FirstCall/ -- Cott Corporation (NYSE: COT; TSX: BCB) announced today the commencement of a cash tender offer by its wholly owned subsidiary, Cott...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

COT - Frequently Asked Questions (FAQ)

What is the current Cotinga Pharmaceuticals share price?
The current share price of Cotinga Pharmaceuticals is $ 0,035
What is the 1 year trading range for Cotinga Pharmaceuticals share price?
Cotinga Pharmaceuticals has traded in the range of $ 0,00 to $ 0,00 during the past year
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
SQGSpackman Equities Group Inc
$ 3,50
(354,55%)
59,45k
KLMKermode Resources Ltd
$ 0,01
(100,00%)
1,42M
GNFIGenifi Inc
$ 0,01
(100,00%)
2k
XBOTRealbotix Corp
$ 0,61
(84,85%)
6,9M
JADEJade Leader Corp
$ 0,04
(60,00%)
177k
AJAAJA Health and Wellness Inc
$ 0,035
(-53,33%)
2k
BYM.HBaymount Incorporated
$ 0,005
(-50,00%)
1.000
ETUE2gold Inc
$ 0,005
(-50,00%)
12,29k
ENTGEntourage Health Corp
$ 0,005
(-50,00%)
16,04k
WWA.PWhitewater Acquisition Corp
$ 0,14
(-48,15%)
5k
XBOTRealbotix Corp
$ 0,61
(84,85%)
6,9M
QNCQuantum Emotion Corp
$ 0,90
(-19,64%)
4,37M
GPUSAlset AI Ventures Inc
$ 0,185
(-11,90%)
4,1M
RHCRoyal Helium Ltd
$ 0,02
(0,00%)
3,47M
THRMTherma Bright Inc
$ 0,04
(-20,00%)
2,71M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock